Exploring
novel p-hydroxyphenylpyruvate dioxygenase
(EC 1.13.11.27, HPPD) inhibitors has become one of the most promising
research directions in herbicide innovation. On the basis of our tremendous
interest in exploiting more powerful HPPD inhibitors, we designed
a family of benzyl-containing triketone-aminopyridines via a structure-based
drug design (SBDD) strategy and then synthesized them. Among these
prepared derivatives, the best active 3-hydroxy-2-(3,5,6-trichloro-4-((4-isopropylbenzyl)amino)picolinoyl)cyclohex-2-en-1-one
(23, IC50 = 0.047 μM) exhibited a 5.8-fold
enhancement in inhibiting Arabidopsis thaliana (At) HPPD activity over that of commercial mesotrione (IC50 = 0.273 μM). The predicted docking models and calculated
energy contributions of the key residues for small molecules suggested
that an additional π–π stacking interaction with
Phe-392 and hydrophobic contacts with Met-335 and Pro-384 were detected
in AtHPPD upon the binding of the best active compound 23 compared with that of the reference mesotrione. Such a
molecular mechanism and the resulting binding affinities coincide
with the proposed design scheme and experimental values. It is noteworthy
that inhibitors 16 (3-hydroxy-2-(3,5,6-trichloro-4-((4-chlorobenzyl)amino)picolinoyl)cyclohex-2-en-1-one), 22 (3-hydroxy-2-(3,5,6-trichloro-4-((4-methylbenzyl)amino)picolinoyl)cyclohex-2-en-1-one),
and 23 displayed excellent greenhouse herbicidal effects
at 150 g of active ingredient (ai)/ha after postemergence treatment.
Furthermore, compound 16 showed superior weed-controlling
efficacy against Setaria viridis (S. viridis) versus that of the positive control mesotrione at multiple test
dosages (120, 60, and 30 g ai/ha). These findings imply that compound 16, as a novel lead of HPPD inhibitors, possesses great potential
for application in specifically combating the malignant weed S. viridis.